Semaglutide

Weight plateaus at 6 months on semaglutide occur due to metabolic adaptation and dose ceiling — learn how to break through stalls with titration

Semaglutide plateaus at 6 months occur when metabolic adaptation meets reduced deficit — dosage adjustment, protein timing, and NEAT restoration break the

Semaglutide fatigue affects 20-40% of patients early in treatment. Learn the biological mechanisms behind it and evidence-based strategies to manage it

Semaglutide headaches affect 15–20% of patients during dose escalation. Learn what causes them, when they resolve, and evidence-based relief strategies.

Semaglutide calorie intake targets range from 1200–1500 daily for effective fat loss while preserving muscle. Here’s what works and what doesn’t.

Semaglutide dizziness occurs in 15–20% of patients during titration due to blood pressure changes, dehydration, and blood sugar shifts—here’s what helps.

Semaglutide rarely causes heart palpitations directly, but GI distress, dehydration, and electrolyte shifts can trigger them. Here’s what patients should

Semaglutide carries a documented pancreatitis risk in 0.2–1% of patients. Learn exact symptoms, risk factors, and how to distinguish medication-induced

Semaglutide shows protective effects on kidney function in clinical trials, reducing albuminuria and slowing progression of diabetic kidney disease.